Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia.
暂无分享,去创建一个
N. Muñoz | E. Weiderpass | C. Meijer | S. Morré | A. V. D. van den Brule | M. Molano | A. Arslan | H. Posso | M. Ronderos | S. Franceschi
[1] S. Franceschi,et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology , 2002, British Journal of Cancer.
[2] P. Coursaget,et al. Risk factors of invasive cervical cancer in Mali. , 2002, International journal of epidemiology.
[3] N. Muñoz,et al. HPV types and cofactors causing cervical cancer in Peru , 2001, British Journal of Cancer.
[4] P. Saikku,et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. , 2001, JAMA.
[5] P. Castle,et al. Chlamydia trachomatis and cervical squamous cell carcinoma. , 2001, JAMA.
[6] N. Muñoz,et al. Human papillomavirus infection and invasive cervical cancer in Paraguay , 2000, International journal of cancer.
[7] T. Bjørge,et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer , 2000, International journal of cancer.
[8] S. Kjaer,et al. PCR-detected Chlamydia trachomatis infections from the uterine cervix of young women from the general population: prevalence and risk determinants. , 1999, Sexually transmitted diseases.
[9] T. Wright,et al. Cervical ectopy and the transformation zone measured by computerized planimetry in adolescents , 1999, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[10] I. Nindl,et al. Detection of Chlamydia trachomatis DNA in cervical samples with regard to infection by human papillomavirus. , 1999, The Journal of infection.
[11] J. Walboomers,et al. Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification. , 1998, Molecular pathology : MP.
[12] N. Muñoz,et al. The viral origin of cervical cancer in Rabat, Morocco , 1998, International journal of cancer.
[13] Y. V. van Duynhoven,et al. Chlamydia trachomatis genotypes: correlation with clinical manifestations of infection and patients' characteristics. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] F. X. Bosch,et al. Causes of cervical cancer in the Philippines: a case-control study. , 1998, Journal of the National Cancer Institute.
[15] F. X. Bosch,et al. Risk factors for cervical cancer in Thailand: a case-control study. , 1998, Journal of the National Cancer Institute.
[16] M. Sherman,et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[17] T. Bjørge,et al. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. , 1997, Journal of the National Cancer Institute.
[18] G. Ridgway,et al. Comparison of two methods of screening for genital chlamydial infection in women attending in general practice: cross sectional survey , 1997, BMJ.
[19] C. Meijer,et al. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings , 1997, Journal of clinical microbiology.
[20] H. Handsfield,et al. Performance and Cost‐Effectiveness of Selective Screening Criteria for Chlamydia trachomatis Infection in Women: Implications for a National Chlamydia Control Strategy , 1997, Sexually transmitted diseases.
[21] W. M. Mac Kenzie,et al. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. , 1997, American journal of obstetrics and gynecology.
[22] J. Walboomers,et al. RNA amplification by nucleic acid sequence-based amplification with an internal standard enables reliable detection of Chlamydia trachomatis in cervical scrapings and urine samples , 1996, Journal of clinical microbiology.
[23] J. Barrow,et al. A Tale of Two Sexually Transmitted Diseases: Prevalences and Predictors of Chlamydia and Gonorrhea in Women Attending Colorado Family Planning Clinics , 1996, Sexually transmitted diseases.
[24] J. Walboomers,et al. Prevalence and serovar distribution of asymptomatic cervical Chlamydia trachomatis infections as determined by highly sensitive PCR , 1995, Journal of clinical microbiology.
[25] J. Walboomers,et al. Chlamydia trachomatis and ectopic pregnancy: retrospective analysis of salpingectomy specimens, endometrial biopsies, and cervical smears. , 1995, Journal of clinical pathology.
[26] C. Meijer,et al. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. , 1995, The Journal of general virology.
[27] C. Meijer,et al. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction , 1994, International journal of cancer.
[28] F. X. Bosch,et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[29] R. Peto,et al. Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. , 1993, American journal of epidemiology.
[30] J. Kaldor,et al. The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spain , 1992, International journal of cancer.
[31] D. Hunter,et al. Chlamydia trachomatis and oral contraceptive use: a quantitative review. , 1992, Genitourinary medicine.
[32] S. Thompson,et al. Pelvic Inflammatory Disease and Fertility: A Cohort Study of 1,844 Women with Laparoscopically Verified Disease and 657 Control Women with Normal Laparoscopic Results , 1992, Sexually transmitted diseases.
[33] M. Pearlman,et al. A review of the microbiology, immunology, and clinical implications of Chlamydia trachomatis infections. , 1992, Obstetrical & gynecological survey.
[34] R. Sweet,et al. Long-term sequelae of acute pelvic inflammatory disease. A retrospective cohort study. , 1992, American journal of obstetrics and gynecology.
[35] C. Meijer,et al. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction , 1990, Journal of clinical microbiology.
[36] S. Bagshaw,et al. Risk factors for Chlamydia trachomatis infection of the cervix: a prospective study of 2000 patients at a family planning clinic. , 1987, The New Zealand medical journal.